Abstract P5-15-07: First and further line choices of treatment for HER2-VE metastatic breast cancer (MBC) according to adjuvant treatment and biological subtype. Preliminary results of the observational “GIM-13 – AMBRA” Italian study

Giorgio Mustacchi, Anna Turletti, Laura Biganzoli et al.|Cancer Research|2017

Cited by 0